Breadcrumb

  1. Insights
  2. Investigations Blog

Investigations Blog

402 total results. Page 1 of 17.

Investigations Blog
Eleventh Circuit Actively Engaged on Question of FCA’s Qui Tam Provisions’ Constitutionality
Nadia Patel, John M. Hindley

On December 12, the Eleventh Circuit heard the much-anticipated oral arguments in United States ex rel. Zafirov v. Florida Medical Associates LLC concerning the constitutionality of the False Claims Act’s (FCA) qui tam provisions.

Investigations Blog
DOJ Once Again to Corporate Community: White Collar Criminal Enforcement Not Slowing Down
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, Rebekkah R.N. Stoeckler, Sean A. Worley

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
CVS to Pay $37.8 Million to Settle Overbilling Claims
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, John M. Hindley, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Zafirov One Year Later: Constitutional Challenges to the False Claims Act’s Qui Tam Provision
Nadia Patel, John M. Hindley

Judge Kathryn Kimball Mizelle’s ground-breaking decision in Zafirov v. Florida Medical Associates LLC and Justice Clarence Thomas’ solo dissent in US ex rel. Polansky v. Executive Health Resources Inc. have revived what many had viewed as a settled constitutional question.

Investigations Blog
Medtronic FCA Claims Survive Reconsideration Despite First Circuit’s But-For Causation Standard
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Pascal Naples, James G. Pizzo

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Jury Finds Global Health Care Company Novo Nordisk Not Liable in Whistleblower’s FCA Suit
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, James G. Pizzo

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Fifth Circuit Judge Questions Constitutionality of the FCA’s Qui Tam Provision
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Meghan F. Hart, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Brothers Convicted in $100 Million HIV Drug Fraud Scheme
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Private Equity Firm Not Liable for Alleged FCA Retaliation Claims by Former Employee of Portfolio Company
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Seizes $15 Billion in Bitcoin in Cryptocurrency Fraud Scheme
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth Satarov, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Fourth Circuit Appeal Challenges Six-Year Sentence in $10 Million Medicaid Fraud Case
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Mattie Bowden, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
$37 Million FCA Settlement: Semler Scientific and Bard Resolve Medicare False Claims Over FloChec/QuantaFlo
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Mattie Bowden, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Remarks by Acting Assistant Attorney General Matthew R. Galeotti Regarding White Collar Enforcement Priorities
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Apeksha Vora, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Ninth Circuit Restores FCA Case Against Biotronik
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Omni Healthcare Ordered to Pay Attorney Fees for Vexatious FCA Litigation
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Roberto Martinez, Heather M. Zimmer

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Seventh Circuit Affirms Dismissal of FCA Retaliation Suit Against AbbVie for Alleged Off-Label Promotion
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Pascal Naples, James G. Pizzo

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Files Brief in Johnson & Johnson’s Appeal of $1.6 Billion FCA Verdict
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Roberto Martinez, Pascal Naples

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Allied Stone Inc. and Its President Agree to Pay $12.4 Million to Settle FCA Claims Relating to Evaded Customs Duties
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, John M. Hindley, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Texas Alleges That Eli Lilly Patient Assistance Programs Violates AKS
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Regeneron Court Permits Government to Pursue False Certification Theory
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Patio Furniture Firm Pays Millions for Dodging Import Duties
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth Satarov, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Johnson & Johnson Challenges the Constitutionality of FCA $1.6 Billion Verdict
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Pascal Naples, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
IT Company Resolves FCA Allegations for Nearly $15 Million
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Apeksha Vora, Nardeen Billan

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Federal Court Imposes Nearly $1 Billion in FCA Damages and Penalties Against Omnicare and CVS
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Apeksha Vora, Heather M. Zimmer, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ and HHS Emphasize Continued, Robust, and Coordinated Health Care Enforcement With Revival of False Claims Act Working Group
D. Jacques Smith, Nadia Patel, Michelle J. Shapiro, Stephanie Trunk, Pascal Naples, Rebekkah R.N. Stoeckler

The government has announced a renewed and expanded focus on False Claims Act (FCA) enforcement, doubling down on traditional health care priorities like kickbacks and drug pricing while signaling increased scrutiny of Electronic Health Records (EHR) manipulation.